Live Breaking News & Updates on Aezs

Stay informed with the latest breaking news from Aezs on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Aezs and stay connected to the pulse of your community

Aeterna Zentaris (NASDAQ:AEZS) Research Coverage Started at StockNews.com

StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note published on Tuesday morning. The brokerage issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Trading Down 3.8 % AEZS stock opened at $2.01 on Tuesday. The firm has a market cap of $9.76 million, a […]

Aeterna-zentaris , Aeterna-zentaris-company-profile , Aeterna-zentaris-inc , Free-report , Zentaris-trading-down , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical

StockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)

StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Tuesday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Stock Performance Shares of NASDAQ:AEZS opened at $2.01 on Tuesday. The stock’s 50-day simple moving average is $2.00 and its […]

Aeterna-zentaris-company-profile , Aeterna-zentaris-inc , Aeterna-zentaris , Nasdaq , Free-report , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical

StockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)

StockNews.com began coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research note issued to investors on Tuesday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Aeterna Zentaris Stock Up 7.2 % AEZS opened at $2.09 on Tuesday. The company has a 50 day moving average of […]

Aeterna-zentaris-inc , Aeterna-zentaris , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical , Initiated-coverage , Stocknews-com ,

Aeterna Zentaris Inc. (NASDAQ:AEZS) Short Interest Update

Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) was the recipient of a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 16,900 shares, a decrease of 22.1% from the March 31st total of 21,700 shares. Based on an average daily volume of 15,900 […]

Aeterna-zentaris-inc , Nasdaq , Aeterna-zentaris , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical , Stocks , Options

Aeterna Zentaris Inc. (NASDAQ:AEZS) Short Interest Update

Aeterna Zentaris Inc. (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) saw a large decrease in short interest in the month of April. As of April 15th, there was short interest totalling 16,900 shares, a decrease of 22.1% from the March 31st total of 21,700 shares. Approximately 0.4% of the shares of the company are sold short. […]

Nasdaq , Aeterna-zentaris-company-profile , Aeterna-zentaris-inc , Aeterna-zentaris , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical , Stocks

Aeterna Zentaris (TSE:AEZS) Stock Price Up 2.9%

Aeterna Zentaris Inc. (TSE:AEZS – Get Free Report)’s share price was up 2.9% during trading on Wednesday . The stock traded as high as C$2.85 and last traded at C$2.85. Approximately 118 shares traded hands during trading, a decline of 94% from the average daily volume of 1,993 shares. The stock had previously closed at […]

Aeterna-zentaris , Aeterna-zentaris-inc , Get-free-report , Zentaris-trading-down , Zentaris-inc , Aeterna-zentaris-daily , Tse-aezs , Aezs , Medical , Stocks , Technicals

Aeterna Zentaris (NASDAQ:AEZS) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research report report published on Saturday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Aeterna Zentaris Price Performance NASDAQ:AEZS opened at $2.06 on Friday. The firm’s fifty day moving average price is $1.93 and its 200 […]

Aeterna-zentaris , Aeterna-zentaris-inc , Nasdaq , Aeterna-zentaris-company-profile , Free-report , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical

StockNews.com Initiates Coverage on Aeterna Zentaris (NASDAQ:AEZS)

StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a report published on Sunday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reduced their price objective on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating for the company […]

Nasdaq , Aeterna-zentaris-company-profile , Aeterna-zentaris-inc , Aeterna-zentaris , Free-report , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical

Aeterna Zentaris (NASDAQ:AEZS) Coverage Initiated at StockNews.com

Investment analysts at StockNews.com started coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Get Free Report) (TSE:AEZ) in a research report issued to clients and investors on Friday. The brokerage set a “sell” rating on the biopharmaceutical company’s stock. Separately, HC Wainwright dropped their price target on shares of Aeterna Zentaris from $28.00 to $15.00 […]

Aeterna-zentaris , Aeterna-zentaris-inc , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical , Initiated-coverage , Stocknews-com ,

Aeterna Zentaris (NASDAQ:AEZS) Receives New Coverage from Analysts at StockNews.com

StockNews.com initiated coverage on shares of Aeterna Zentaris (NASDAQ:AEZS – Free Report) (TSE:AEZ) in a research note issued to investors on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock. Separately, HC Wainwright decreased their target price on shares of Aeterna Zentaris from $28.00 to $15.00 and set a buy rating […]

Aeterna-zentaris , Aeterna-zentaris-company-profile , Aeterna-zentaris-inc , Free-report , Get-free-report , Zentaris-inc , Aeterna-zentaris-daily , Nasdaq-aezs , Aezs , Medical , Initiated-coverage